scholarly journals Ribavirin pharmacokinetics and interleukin 28B plus cytochrome P450 27B1 single-nucleotide polymorphisms as predictors of response to pegylated interferon/ribavirin treatment in patients infected with hepatitis C virus genotype 1/4

Hepatology ◽  
2011 ◽  
Vol 54 (6) ◽  
pp. 2279-2279 ◽  
Author(s):  
Antonio D'Avolio ◽  
Alessia Ciancio ◽  
Marco Siccardi ◽  
Lorena Baietto ◽  
Marco Simiele ◽  
...  
Keyword(s):  
Cytochrome P450 ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Pegylated Interferon ◽  
Nucleotide Polymorphisms ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Single Nucleotide ◽  
Interleukin 28B ◽  
Predictors Of Response

scholarly journals Long-term Pegylated Interferon Monotherapy Following 72 Weeks of Pegylated Interferon and Ribavirin in Hepatitis C Virus Genotype-1-infected Slow Responders

2015 ◽  
Vol 54 (3) ◽  
pp. 273-279 ◽  
Author(s):  
Shinya Watanabe ◽  
Yoshimasa Kobayashi ◽  
Kazuhito Kawata ◽  
Hidenao Noritake ◽  
Takeshi Chida ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Pegylated Interferon ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Interferon Monotherapy

scholarly journals Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis

2017 ◽  
Vol 25 (1) ◽  
Author(s):  
Fardin Dolatimehr ◽  
Hamidreza Karimi-Sari ◽  
Mohammad Saeid Rezaee-Zavareh ◽  
Seyed Moayed Alavian ◽  
Bita Behnava ◽  
...  
Keyword(s):  
Systematic Review ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Meta Analysis ◽  
Pegylated Interferon ◽  
Genotype 1 ◽  
Virus Genotype
Sign in / Sign up

Export Citation Format

Share Document